[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=81d51c3b2b4f5c154dc6277fa89c6c6125d4a2c56f9e390ede0f1b71a972b58d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732034520,
      "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "id": 131509093,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=81d51c3b2b4f5c154dc6277fa89c6c6125d4a2c56f9e390ede0f1b71a972b58d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) Jefferies London Healthcare Conference November 19, 2024 4:30 AM ETCompany ParticipantsDavid Elkins -...",
    "url": "https://finnhub.io/api/news?id=3bb1dd9144ff4986cb8e2389c66da22470362e86fbf6b2f92c7113bcea074a5c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732032328,
      "headline": "Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)",
      "id": 131491965,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) Jefferies London Healthcare Conference November 19, 2024 4:30 AM ETCompany ParticipantsDavid Elkins -...",
      "url": "https://finnhub.io/api/news?id=3bb1dd9144ff4986cb8e2389c66da22470362e86fbf6b2f92c7113bcea074a5c"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms",
    "summary": "PRINCETON, N.J., November 19, 2024--BMS' Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms",
    "url": "https://finnhub.io/api/news?id=84e52ba96f39cdc2d5fa1ec401f414b0ef76855b7b99f8ad3ff8bd5231092437",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732017540,
      "headline": "Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms",
      "id": 131469508,
      "image": "https://s.yimg.com/ny/api/res/1.2/629SknYnxJBC5yKsdz9bFg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xNjU-/https://media.zenfs.com/en/business-wire.com/029df730ac198ba09da8f7f492d3b342",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., November 19, 2024--BMS' Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms",
      "url": "https://finnhub.io/api/news?id=84e52ba96f39cdc2d5fa1ec401f414b0ef76855b7b99f8ad3ff8bd5231092437"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)",
    "summary": "Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield support a strong buy upgrade.",
    "url": "https://finnhub.io/api/news?id=46e4224bfbd8c3f561c918851d95bd0871c09f89b08895da85b7b639dfffea12",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732015683,
      "headline": "Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)",
      "id": 131474886,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/107429734/image_107429734.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield support a strong buy upgrade.",
      "url": "https://finnhub.io/api/news?id=46e4224bfbd8c3f561c918851d95bd0871c09f89b08895da85b7b639dfffea12"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers: presents new data to ASH",
    "summary": "Bristol Myers Squibb has announced the presentation of more than 90 data disclosures, including 18 oral presentations, from its hematology and cell therapy research programs at the 66 th Annual...",
    "url": "https://finnhub.io/api/news?id=def577aad605395bf438d52f25d0b2d125a12c2f31392343c72de37b75da3528",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732006032,
      "headline": "Bristol Myers: presents new data to ASH",
      "id": 131470432,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "Bristol Myers Squibb has announced the presentation of more than 90 data disclosures, including 18 oral presentations, from its hematology and cell therapy research programs at the 66 th Annual...",
      "url": "https://finnhub.io/api/news?id=def577aad605395bf438d52f25d0b2d125a12c2f31392343c72de37b75da3528"
    }
  }
]